Discover 4,573 paid clinical trials in New York State. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
New York State presents a wide array of paid research opportunities for both healthy volunteers and those with specific health concerns. Actively recruiting research institutions in New York City, Buffalo, and Rochester offer access to innovative treatments and exceptional medical care near you.
Filter
1
Filter results
Results: 4,573
Virtual Reality for Pain Control in US-Guided Obstetric Needle Procedures
for
Procedural Pain
Location: New York NY
Sponsor: Icahn School of Medicine at Mount Sinai
Sex: Female
Age: 18+
Code: NCT07094451
Recruiting
A Study of Revaree Plus in People With Breast Cancer
for
Breast Cancer, Stage 0 Breast Cancer, Stage I Breast Cancer,
Location: Commack NY, Uniondale NY, Harrison NY, New York NY,
Sponsor: Memorial Sloan Kettering Cancer Center
Sex: Female
Age: 18+
Code: NCT07042581
Recruiting
Feasibility and Effectiveness of Goal Driven Extended Reality for Lower Limb Rehabilitation
Location: Roslyn NY, The Bronx NY, Norfolk VA, Charleston SC,
Sponsor: Abbott Medical Devices
Sex: All
Age: 18+
Code: NCT07069673
Recruiting
Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy
for
Prostate Cancer
Location: Boston MA, Hartford CT, The Bronx NY, New York NY,
Sponsor: Novartis Pharmaceuticals
Sex: Male
Age: 18 - 70+
Code: NCT06780670
Phase 2, Phase 3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Influence of Authorized Smokeless Tobacco Product Modified Risk Claims II: Laboratory Assessment of Sensory and Subjective Effects
for
Smokeless Tobacco
Location: Buffalo NY
Sponsor: Roswell Park Cancer Institute
Sex: All
Age: 21+
Code: NCT07107139
Recruiting
A Study of Ifinatamab Deruxtecan in Subjects With Pretreated Advanced or Metastatic Esophageal Squamous Cell Carcinoma (ESCC) (IDeate-Esophageal01)
for
Esophageal Squamous Cell Carcinoma
Location: Brooklyn NY, Morristown NJ, Hershey PA, Fairfax VA,
Sponsor: Daiichi Sankyo
Sex: All
Age: 18+
Code: NCT06644781
Phase 3, Recruiting
Paracervical Block for Pain Reduction in Saline Infusion Sonograms
for
Pain During Saline Infusion Sonogram
Location: Hartsdale NY
Sponsor: Montefiore Medical Center
Sex: Female
Age: 18 - 50
Code: NCT07048769
Recruiting
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
for
Metastatic Solid Tumor, Recurrent Solid Tumor,
Location: Boston MA, New York NY, Cleveland OH, Atlanta GA,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT06465069
Phase 1, Recruiting
Association Between Exercise, Patient-Reported Outcomes, and Clinical Events in Adult Cancer Survivors
Moving Beyond Inflammation as a Therapeutic Target for Crohn's Disease
for
Crohn Disease (CD)
Location: New York NY, St Louis MO
Sponsor: Washington University School of Medicine
Sex: All
Age: 18 - 70+
Code: NCT06976853
Phase 2, Recruiting
A Study to Investigate the Safety, Tolerability, and Efficacy of SAR446268, an Adeno-associated Viral Vector-mediated Gene Therapy in Participants Aged 10 to 55 Years of Age With Non-congenital Myotonic Dystrophy Type 1
for
Myotonic Dystrophy
Location: New York NY, Montreal, Philadelphia PA, Richmond VA,
Sponsor: Sanofi
Sex: All
Age: 10 - 55
Code: NCT06844214
Phase 1, Phase 2, Recruiting
A Phase 3 Efficacy and Safety Study of Fosmanogepix for the Treatment of Adult Patients With Invasive Mold Infections.
for
Invasive Mold Infections
Location: New York NY, Philadelphia PA, Baltimore MD, Ottawa,
Sponsor: Basilea Pharmaceutica
Sex: All
Age: 18+
Code: NCT06925321
Phase 3, Recruiting
Neonatal Platelet Transfusion Threshold Trial
for
Thrombocytopenia, Neonatal, Platelet Transfusion,
Location: Boston MA, Philadelphia PA, Rochester NY, Durham NC,
Sponsor: NICHD Neonatal Research Network
Sex: All
Age: 0
Code: NCT06676904
Recruiting
A Phase 2 Study of WU-CART-007, an Anti-CD7 Allogeneic CAR-T Cell Therapy in T-Cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma (T-RRex)